Stocks News

LAST PRICE
189.2300
TODAY'S CHANGE (%)
Trending Down-4.0600 (-2.1005%)

Bid / Lots
186.0000/ 1
Ask / Lots
194.9900/ 1
Open / Previous Close
187.7900 / 193.2900
Day Range
Low 186.1600
High 191.4500
52 Week Range
Low 126.9681
High 248.1600
Volume
273,933
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 14, 2024
- Sector Update: Health Care Stocks Advance Pre-Bell Thursday, from 9:20AM ET on Thursday Nov 14, 2024 by MT Newswires
  9:20AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: IBB, XLV, CLPT, PTCT, BGNE
  09:20 AM EST, 11/14/2024 (MT Newswires) -- Health care stocks were advancing pre-bell Thursday as the iShares Biotechnology ETF (IBB) was marginally higher and the Health Care Select Sector SPDR Fund (XLV) was up 0.1% recently. ClearPoint Neuro (CLP...
- Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Powell Speech, from 8:27AM ET on Thursday Nov 14, 2024 by MT Newswires
  8:27AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: GLD, FAS, FAZ, IBB, IGM, IGV, SOXX, IVV, IWM, IYE, IYH, IYJ, IYK, IYW, MUFG, QQQ, SPY, VDC, VHT, VIS, XLE, XLF, XLI, XLK, XLP, XLV, XLY, XSD, RTH, USO, SLV, ASML, XRT, EXI, EH, BITO, UNG, ZK, BGNE, OVV, EEM
  08:27 AM EST, 11/14/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% higher in Thursday's premarket activity, ahead of Fed Chair Jerome Pow...
- BeiGene to Rename as BeOne Medicines, from 7:08AM ET on Thursday Nov 14, 2024 by MT Newswires
  7:08AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BGNE
  07:08 AM EST, 11/14/2024 (MT Newswires) -- BeiGene (BGNE) said Thursday it plans to change its name to BeOne Medicines, subject to shareholder approval. Once the name change is approved, the company's Nasdaq ticker will change to "ONC." The name cha...
- BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer, from 6:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  6:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: BGNE
  
  BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
  -- New name reflects Company's bold vision to eradicate cancer by harnessing the transformative power of global collaboration and multisectoral partnerships -- Company will change its Nasdaq ticker to ONC SAN MATEO, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--November 14, 2024--
Nov 13, 2024
- DJ BeiGene Is Maintained at Buy by TD Cowen, from 1:11PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:11PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: BGNE
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BGNE/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 13, 2024 13:11 ET (18:11 GMT)

Yesterday
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by PR Newswire
  10:45AM ET on Saturday Nov 16, 2024 by PR Newswire
  Companies Mentioned: BMRN
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by Dow Jones
  10:45AM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: BMRN
Nov 15, 2024
- Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target, from 7:22AM ET on Friday Nov 15, 2024 by MT Newswires
  7:22AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BMRN
- DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BMRN
Nov 14, 2024
- Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing, from 2:47PM ET on Thursday Nov 14, 2024 by MT Newswires
  2:47PM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BMRN
Nov 13, 2024
- Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing, from 6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires
  6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy, from 1:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:00PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: EXAS
Nov 11, 2024
- DJ Exact Sciences Is Maintained at Overweight by Piper Sandler, from 8:04AM ET on Monday Nov 11, 2024 by Dow Jones
  8:04AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: EXAS
Nov 7, 2024
- Neurocrine Biosciences Presents New KINECT(R)-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA(R) (valbenazine) Capsules, from 8:30AM ET on Thursday Nov 07, 2024 by PR Newswire
  8:30AM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: NBIX
- Neurocrine Biosciences Presents New KINECT(R)-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA(R) (valbenazine) Capsules, from 8:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: NBIX

Beigene Ltd
NASDAQ:BGNEUnited States

Search Criteria

Nov 14, 2024

Sector Update: Health Care Stocks Advance Pre-Bell Thursday, from 9:20AM ET on Thursday Nov 14, 2024 by MT Newswires

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Powell Speech, from 8:27AM ET on Thursday Nov 14, 2024 by MT Newswires

BeiGene to Rename as BeOne Medicines, from 7:08AM ET on Thursday Nov 14, 2024 by MT Newswires

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer, from 6:00AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

DJ BeiGene Is Maintained at Buy by TD Cowen, from 1:11PM ET on Wednesday Nov 13, 2024 by Dow Jones

Peers Headlines

Yesterday

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by PR Newswire

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by Dow Jones

Nov 15, 2024

Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target, from 7:22AM ET on Friday Nov 15, 2024 by MT Newswires

DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing, from 2:47PM ET on Thursday Nov 14, 2024 by MT Newswires

Nov 13, 2024

Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing, from 6:29PM ET on Wednesday Nov 13, 2024 by MT Newswires

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy, from 1:00PM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 11, 2024

DJ Exact Sciences Is Maintained at Overweight by Piper Sandler, from 8:04AM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

Neurocrine Biosciences Presents New KINECT(R)-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA(R) (valbenazine) Capsules, from 8:30AM ET on Thursday Nov 07, 2024 by PR Newswire

Neurocrine Biosciences Presents New KINECT(R)-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA(R) (valbenazine) Capsules, from 8:30AM ET on Thursday Nov 07, 2024 by Dow Jones